BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17707747)

  • 1. Disseminated tuberculosis after anti-TNFalpha treatment.
    Iizuka M; Watanabe S
    Lancet; 2007 Aug; 370(9587):564; author reply 565. PubMed ID: 17707747
    [No Abstract]   [Full Text] [Related]  

  • 2. Disseminated tuberculosis after anti-TNFalpha treatment.
    Agarwal R; Srinivas R; Gupta D
    Lancet; 2007 Aug; 370(9587):564; author reply 565. PubMed ID: 17707746
    [No Abstract]   [Full Text] [Related]  

  • 3. Disseminated tuberculosis after anti-TNFalpha treatment.
    Malipeddi AS; Rajendran R; Kallarackal G
    Lancet; 2007 Jan; 369(9556):162. PubMed ID: 17223480
    [No Abstract]   [Full Text] [Related]  

  • 4. [Disseminated tuberculosis in patient with rheumatoid arthritis after infliximab therapy].
    Ramos González A; Corzo Delgado JE; Sánchez Bursón J
    Med Clin (Barc); 2002 Nov; 119(16):636-7. PubMed ID: 12433341
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible miliary tuberculosis during adalimumab therapy with negative gamma-IFN release assays.
    Endean AL; Barry SM; Young-Min SA
    Rheumatology (Oxford); 2009 Mar; 48(3):319-20. PubMed ID: 19109314
    [No Abstract]   [Full Text] [Related]  

  • 6. Difficult diagnosis of infliximab-related miliary tuberculosis.
    Contini S; Raimondi G; Graziano P; Saltini C; Bocchino M
    Monaldi Arch Chest Dis; 2004; 61(2):128-30. PubMed ID: 15510715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of fatal tuberculosis in a patient with rheumatoid arthritis after three years of treatment with infliximab: comment on the article by Wolfe et al.
    Molenaar ET; Bultink IE; Dijkmans BA; Lems WF
    Arthritis Rheum; 2005 Apr; 52(4):1334-6. PubMed ID: 15818690
    [No Abstract]   [Full Text] [Related]  

  • 8. Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab.
    Schoe A; van der Laan-Baalbergen NE; Huizinga TW; Breedveld FC; van Laar JM
    Arthritis Rheum; 2006 Feb; 55(1):157-9. PubMed ID: 16463430
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculous peritonitis after treatment with adalimumab.
    Antolín J; Azahara M; Hernández C; Blanco M; Mao L; Cigüenza R
    Scand J Infect Dis; 2008; 40(8):677-8. PubMed ID: 18979608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Hochman D; Wolff B
    JAMA; 2006 Nov; 296(18):2203; author reply 2203-4. PubMed ID: 17090763
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Callegari PE; Schaible TF; Boscia JA
    JAMA; 2006 Nov; 296(18):2202; author reply 2203-4. PubMed ID: 17090762
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis.
    Costenbader KH; Glass R; Cui J; Shadick N
    JAMA; 2006 Nov; 296(18):2201; author reply 2203-4. PubMed ID: 17090761
    [No Abstract]   [Full Text] [Related]  

  • 13. Adalimumab-induced lupus erythematosus.
    Martín JM; Ricart JM; Alcácer J; Rausell N; Arana G
    Lupus; 2008 Jul; 17(7):676-8. PubMed ID: 18625641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of adalimumab-associated interstitial pneumonia with rheumatoid arthritis.
    Yamazaki H; Isogai S; Sakurai T; Nagasaka K
    Mod Rheumatol; 2010 Oct; 20(5):518-21. PubMed ID: 20467775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miller-Fisher syndrome in a patient with rheumatoid arthritis treated with adalimumab.
    Kurmann PT; Van Linthoudt D; So AK
    Clin Rheumatol; 2009 Jan; 28(1):93-4. PubMed ID: 18818868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab.
    Kalyoncu U; Karadag O; Akdogan A; Kisacik B; Erman M; Erguven S; Ertenli AI
    Scand J Infect Dis; 2007; 39(5):475-8. PubMed ID: 17464877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity and mortality in rheumatoid patients during treatment with adalimumab and infliximab.
    Molloy E; Ramakrishnan S; Murphy E; Barry M
    Rheumatology (Oxford); 2004 Apr; 43(4):522-3. PubMed ID: 15024136
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute generalized skin eruption due to adalimumab: report of two cases.
    Dalmau J; Roé E; Corella F; García-Navarro X; Peramiquel L; Alomar A
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1105-6. PubMed ID: 17714134
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fatal miliary tuberculosis during treatment with infliximab].
    Vonkeman HE; van der Valk PD; Mulder L; van de Laar MA
    Ned Tijdschr Geneeskd; 2002 Jun; 146(25):1196-9. PubMed ID: 12109312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alopecia areata universalis during treatment of rheumatoid arthritis with anti-TNF-alpha antibody (adalimumab).
    Chaves Y; Duarte G; Ben-Said B; Tebib J; Berard F; Nicolas JF
    Dermatology; 2008; 217(4):380. PubMed ID: 18849606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.